CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Open-market sale EVP & General Counsel sold 25,000 shares at $46.18 ($1,154,500)
- 4 Planned sale EVP, Commercial sold 136,383 shares at an average $47.58 ($6,488,503)
- 4 Open-market sale EVP Prod Dev & Med Aff & CMO sold 72,776 shares at $45.47 ($3,309,125)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CSO/EVP Disc & Trans Research sold 1,508 shares at $39.00 ($58,812)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 159,383 shares (grant or award)
Page 8 of 126 · 2,517 filings